{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:28:52Z","timestamp":1794742132917,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021316","name":"AstraZeneca Pharmaceuticals LP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.atherosclerosis.2025.120228","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:31:08Z","timestamp":1748399468000},"page":"120228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Differential cardiovascular impact of \u03c9-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial"],"prefix":"10.1016","volume":"408","author":[{"given":"Tom Kai Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"St John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Wolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-6464","authenticated-orcid":false,"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.120228_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American college of cardiology solution set oversight committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib2","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib5","first-page":"528","article-title":"Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial","volume":"143","author":"Kalstad","year":"2021","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib7","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/jamacardio.2021.1157","article-title":"Association between achieved \u03c9-3 fatty acid levels and major adverse cardiovascular outcomes in patients with high cardiovascular risk: a secondary analysis of the STRENGTH trial","volume":"6","author":"Nissen","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib9","first-page":"1863","article-title":"Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis","volume":"31","author":"Dinu","year":"2024","journal-title":"European journal of preventive cardiology"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102245","article-title":"Assessing the efficacy of Omega-3 fatty acids + statins vs. statins only on cardiovascular outcomes: a systematic review and meta-analysis of 40,991 patients","volume":"49","author":"Irfan","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21878-x","article-title":"Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: nhanes 2011-2018","volume":"12","author":"Lopez-Neyman","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jacasi.2021.05.001","article-title":"Inter-ethnic differences in cardiovascular disease: impact on therapies and outcomes","volume":"1","author":"Hahn","year":"2021","journal-title":"JACC Asia"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/clc.23055","article-title":"Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: rationale and design of the STRENGTH trial","volume":"41","author":"Nicholls","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib14","first-page":"1","article-title":"Trends in the use of complementary health approaches among adults: united States, 2002-2012","author":"Clarke","year":"2015","journal-title":"National health statistics reports"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib15","first-page":"372","volume":"146","author":"Ridker","year":"2022","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamacardio.2022.3698","article-title":"When is a placebo not a placebo","volume":"7","author":"Nissen","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib17","first-page":"380","article-title":"Trials and tribulations of randomized clinical trials","volume":"146","author":"Harrington","year":"2022","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.atherosclerosis.2025.120228_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2021.1489","article-title":"Effect of marine Omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial","volume":"325","author":"Albert","year":"2021","journal-title":"JAMA"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025011268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025011268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:31:17Z","timestamp":1777192277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025011268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":18,"alternative-id":["S0021915025011268"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120228","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential cardiovascular impact of \u03c9-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120228"}}